Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Bradley T Busebee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Disease Progression, Pancreatic Neoplasms. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
Intraductal papillary mucinous neoplasms (IPMNs) are the most commonly identified pancreatic cystic neoplasms. Incidentally detected IPMNs are common among liver transplant recipients. The risk of IPMN progression to pancreatic cancer in transplant recipients and the impact of immunosuppression on the risk of malignant transformation of IPMN are unclear.
Methods
In this retrospective study of consecutive liver transplant recipients across Mayo Clinic over a 13‐year period, patients were assessed for possible IPMN by automated chart review. Pancreatic cystic lesions were characterized as suspected IPMNs based on imaging criteria. Cox proportional hazards models were used to determine the association between IPMN progression (the development of cancer or worrisome features) and clinical and immunosuppression regimen characteristics.
Results
Of 146 patients with suspected IPMNs, progression occurred in 7 patients (2 cases of IPMN‐associated cancer and 5 cases of worrisome features) over an average follow‐up of 66.6 months. Immunosuppression type, medication number, and tacrolimus trough levels were not associated with IPMN progression ( p > 0.05). Combined kidney and liver transplantation ( p = 0.005) and pretransplant cholangiocarcinoma ( p = 0.012) were associated with IPMN progression.
Conclusion
IPMN progression is rare after liver transplantation even over an extended follow‐up period. The findings were notable for the absence of an association between IPMN progression and immunosuppression regimen. Larger studies are needed given the low incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Health Sciences and Research, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Bradley T Busebee
Zitieren
APA
Busebee, B. T., Chin, J. Y., Mara, K., Johnson, B., Takahashi, N., Majumder, S., & Watt, K. D. (2024). Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15431
Vancouver
Busebee BT, Chin JY, Mara K, Johnson B, Takahashi N, Majumder S, et al. Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15431
BibTeX
@article{Busebee2024,
author = {Busebee, Bradley T and Chin, Jerry Yung-Lun and Mara, Kristin and Johnson, Brad and Takahashi, Naoki and Majumder, Shounak and Watt, Kymberly D},
title = {Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15431}
}
EUVIMED